Covid-19 Impact on Global Recombinant Human EGF Market Size, Status and Forecast 2020-2026
Human EGF is a 6-kDa protein with 53 amino acid residues and three intramolecular disulfide bonds. EGF binds to the epidermal growth factor receptor. Initially, human EGF was known as urogastrone.
This report studies the Recombinant Human EGF (Epidermal Growth Factor) obtained by recombinant protein.
EGF acts by binding with high affinity to epidermal growth factor receptor (EGFR) on the cell surface.
This stimulates ligand-induced dimerization, activating the intrinsic protein-tyrosine kinase activity of the receptor.
The tyrosine kinase activity, in turn, initiates a signal transduction cascade that results in a variety of biochemical changes within the cell – a rise in intracellular calcium levels, increased glycolysis and protein synthesis, and increases in the expression of certain genes including the gene for EGFR – that ultimately lead to DNA synthesis and cell proliferation.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Recombinant Human EGF market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Recombinant Human EGF industry.
Based on our recent survey, we have several different scenarios about the Recombinant Human EGF YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Recombinant Human EGF will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Recombinant Human EGF market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Recombinant Human EGF market in terms of revenue.
Players, stakeholders, and other participants in the global Recombinant Human EGF market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Recombinant Human EGF market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Recombinant Human EGF market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Recombinant Human EGF market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Recombinant Human EGF market.
The following players are covered in this report:
This report studies the Recombinant Human EGF (Epidermal Growth Factor) obtained by recombinant protein.
EGF acts by binding with high affinity to epidermal growth factor receptor (EGFR) on the cell surface.
This stimulates ligand-induced dimerization, activating the intrinsic protein-tyrosine kinase activity of the receptor.
The tyrosine kinase activity, in turn, initiates a signal transduction cascade that results in a variety of biochemical changes within the cell – a rise in intracellular calcium levels, increased glycolysis and protein synthesis, and increases in the expression of certain genes including the gene for EGFR – that ultimately lead to DNA synthesis and cell proliferation.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Recombinant Human EGF market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Recombinant Human EGF industry.
Based on our recent survey, we have several different scenarios about the Recombinant Human EGF YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Recombinant Human EGF will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Recombinant Human EGF market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Recombinant Human EGF market in terms of revenue.
Players, stakeholders, and other participants in the global Recombinant Human EGF market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Recombinant Human EGF market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Recombinant Human EGF market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Recombinant Human EGF market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Recombinant Human EGF market.
The following players are covered in this report:
- FUJIFILM Irvine Scientific
- PeproTech, Inc
- R&D Systems (Bio-Techne)
- Miltenyi Biotec
- Thermo Fisher Scientific
- Abcam PLC
- BioLegend Way
- STEMCELL Technologies
- Eurofins DiscoverX
- RayBiotech, Inc
- Prospec-Tany
- Tonbo Biosciences
- EnQuire Bio
- ScienCell Research Laboratories
- BioVision, Inc
- Abm Inc
- Cell Guidance Systems
- Creative BioMart
- Sino Biological
- Cell Sciences
- Axol Bioscience
- ?98% SDS-PAGE
- 95%-98% SDS-PAGE
- <95% SDS-PAGE
- Scientific Research
- Medical Drug
- Others
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Recombinant Human EGF Revenue
1.4 Market Analysis by Type
1.4.1 Global Recombinant Human EGF Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 ?98% SDS-PAGE
1.4.3 95%-98% SDS-PAGE
1.4.4 <95% SDS-PAGE
1.5 Market by Application
1.5.1 Global Recombinant Human EGF Market Share by Application: 2020 VS 2026
1.5.2 Scientific Research
1.5.3 Medical Drug
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Recombinant Human EGF Industry Impact
1.6.1 How the Covid-19 is Affecting the Recombinant Human EGF Industry
1.6.1.1 Recombinant Human EGF Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Recombinant Human EGF Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Recombinant Human EGF Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Recombinant Human EGF Market Perspective (2015-2026)
2.2 Recombinant Human EGF Growth Trends by Regions
2.2.1 Recombinant Human EGF Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Recombinant Human EGF Historic Market Share by Regions (2015-2020)
2.2.3 Recombinant Human EGF Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Recombinant Human EGF Market Growth Strategy
2.3.6 Primary Interviews with Key Recombinant Human EGF Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Recombinant Human EGF Players by Market Size
3.1.1 Global Top Recombinant Human EGF Players by Revenue (2015-2020)
3.1.2 Global Recombinant Human EGF Revenue Market Share by Players (2015-2020)
3.1.3 Global Recombinant Human EGF Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Recombinant Human EGF Market Concentration Ratio
3.2.1 Global Recombinant Human EGF Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Recombinant Human EGF Revenue in 2019
3.3 Recombinant Human EGF Key Players Head office and Area Served
3.4 Key Players Recombinant Human EGF Product Solution and Service
3.5 Date of Enter into Recombinant Human EGF Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Recombinant Human EGF Historic Market Size by Type (2015-2020)
4.2 Global Recombinant Human EGF Forecasted Market Size by Type (2021-2026)
5 RECOMBINANT HUMAN EGF BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Recombinant Human EGF Market Size by Application (2015-2020)
5.2 Global Recombinant Human EGF Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Recombinant Human EGF Market Size (2015-2020)
6.2 Recombinant Human EGF Key Players in North America (2019-2020)
6.3 North America Recombinant Human EGF Market Size by Type (2015-2020)
6.4 North America Recombinant Human EGF Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Recombinant Human EGF Market Size (2015-2020)
7.2 Recombinant Human EGF Key Players in Europe (2019-2020)
7.3 Europe Recombinant Human EGF Market Size by Type (2015-2020)
7.4 Europe Recombinant Human EGF Market Size by Application (2015-2020)
8 CHINA
8.1 China Recombinant Human EGF Market Size (2015-2020)
8.2 Recombinant Human EGF Key Players in China (2019-2020)
8.3 China Recombinant Human EGF Market Size by Type (2015-2020)
8.4 China Recombinant Human EGF Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Recombinant Human EGF Market Size (2015-2020)
9.2 Recombinant Human EGF Key Players in Japan (2019-2020)
9.3 Japan Recombinant Human EGF Market Size by Type (2015-2020)
9.4 Japan Recombinant Human EGF Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Recombinant Human EGF Market Size (2015-2020)
10.2 Recombinant Human EGF Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Recombinant Human EGF Market Size by Type (2015-2020)
10.4 Southeast Asia Recombinant Human EGF Market Size by Application (2015-2020)
11 INDIA
11.1 India Recombinant Human EGF Market Size (2015-2020)
11.2 Recombinant Human EGF Key Players in India (2019-2020)
11.3 India Recombinant Human EGF Market Size by Type (2015-2020)
11.4 India Recombinant Human EGF Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Recombinant Human EGF Market Size (2015-2020)
12.2 Recombinant Human EGF Key Players in Central & South America (2019-2020)
12.3 Central & South America Recombinant Human EGF Market Size by Type (2015-2020)
12.4 Central & South America Recombinant Human EGF Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 FUJIFILM Irvine Scientific
13.1.1 FUJIFILM Irvine Scientific Company Details
13.1.2 FUJIFILM Irvine Scientific Business Overview and Its Total Revenue
13.1.3 FUJIFILM Irvine Scientific Recombinant Human EGF Introduction
13.1.4 FUJIFILM Irvine Scientific Revenue in Recombinant Human EGF Business (2015-2020))
13.1.5 FUJIFILM Irvine Scientific Recent Development
13.2 PeproTech, Inc
13.2.1 PeproTech, Inc Company Details
13.2.2 PeproTech, Inc Business Overview and Its Total Revenue
13.2.3 PeproTech, Inc Recombinant Human EGF Introduction
13.2.4 PeproTech, Inc Revenue in Recombinant Human EGF Business (2015-2020)
13.2.5 PeproTech, Inc Recent Development
13.3 R&D Systems (Bio-Techne)
13.3.1 R&D Systems (Bio-Techne) Company Details
13.3.2 R&D Systems (Bio-Techne) Business Overview and Its Total Revenue
13.3.3 R&D Systems (Bio-Techne) Recombinant Human EGF Introduction
13.3.4 R&D Systems (Bio-Techne) Revenue in Recombinant Human EGF Business (2015-2020)
13.3.5 R&D Systems (Bio-Techne) Recent Development
13.4 Miltenyi Biotec
13.4.1 Miltenyi Biotec Company Details
13.4.2 Miltenyi Biotec Business Overview and Its Total Revenue
13.4.3 Miltenyi Biotec Recombinant Human EGF Introduction
13.4.4 Miltenyi Biotec Revenue in Recombinant Human EGF Business (2015-2020)
13.4.5 Miltenyi Biotec Recent Development
13.5 Thermo Fisher Scientific
13.5.1 Thermo Fisher Scientific Company Details
13.5.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
13.5.3 Thermo Fisher Scientific Recombinant Human EGF Introduction
13.5.4 Thermo Fisher Scientific Revenue in Recombinant Human EGF Business (2015-2020)
13.5.5 Thermo Fisher Scientific Recent Development
13.6 Abcam PLC
13.6.1 Abcam PLC Company Details
13.6.2 Abcam PLC Business Overview and Its Total Revenue
13.6.3 Abcam PLC Recombinant Human EGF Introduction
13.6.4 Abcam PLC Revenue in Recombinant Human EGF Business (2015-2020)
13.6.5 Abcam PLC Recent Development
13.7 BioLegend Way
13.7.1 BioLegend Way Company Details
13.7.2 BioLegend Way Business Overview and Its Total Revenue
13.7.3 BioLegend Way Recombinant Human EGF Introduction
13.7.4 BioLegend Way Revenue in Recombinant Human EGF Business (2015-2020)
13.7.5 BioLegend Way Recent Development
13.8 STEMCELL Technologies
13.8.1 STEMCELL Technologies Company Details
13.8.2 STEMCELL Technologies Business Overview and Its Total Revenue
13.8.3 STEMCELL Technologies Recombinant Human EGF Introduction
13.8.4 STEMCELL Technologies Revenue in Recombinant Human EGF Business (2015-2020)
13.8.5 STEMCELL Technologies Recent Development
13.9 Eurofins DiscoverX
13.9.1 Eurofins DiscoverX Company Details
13.9.2 Eurofins DiscoverX Business Overview and Its Total Revenue
13.9.3 Eurofins DiscoverX Recombinant Human EGF Introduction
13.9.4 Eurofins DiscoverX Revenue in Recombinant Human EGF Business (2015-2020)
13.9.5 Eurofins DiscoverX Recent Development
13.10 RayBiotech, Inc
13.10.1 RayBiotech, Inc Company Details
13.10.2 RayBiotech, Inc Business Overview and Its Total Revenue
13.10.3 RayBiotech, Inc Recombinant Human EGF Introduction
13.10.4 RayBiotech, Inc Revenue in Recombinant Human EGF Business (2015-2020)
13.10.5 RayBiotech, Inc Recent Development
13.11 Prospec-Tany
10.11.1 Prospec-Tany Company Details
10.11.2 Prospec-Tany Business Overview and Its Total Revenue
10.11.3 Prospec-Tany Recombinant Human EGF Introduction
10.11.4 Prospec-Tany Revenue in Recombinant Human EGF Business (2015-2020)
10.11.5 Prospec-Tany Recent Development
13.12 Tonbo Biosciences
10.12.1 Tonbo Biosciences Company Details
10.12.2 Tonbo Biosciences Business Overview and Its Total Revenue
10.12.3 Tonbo Biosciences Recombinant Human EGF Introduction
10.12.4 Tonbo Biosciences Revenue in Recombinant Human EGF Business (2015-2020)
10.12.5 Tonbo Biosciences Recent Development
13.13 EnQuire Bio
10.13.1 EnQuire Bio Company Details
10.13.2 EnQuire Bio Business Overview and Its Total Revenue
10.13.3 EnQuire Bio Recombinant Human EGF Introduction
10.13.4 EnQuire Bio Revenue in Recombinant Human EGF Business (2015-2020)
10.13.5 EnQuire Bio Recent Development
13.14 ScienCell Research Laboratories
10.14.1 ScienCell Research Laboratories Company Details
10.14.2 ScienCell Research Laboratories Business Overview and Its Total Revenue
10.14.3 ScienCell Research Laboratories Recombinant Human EGF Introduction
10.14.4 ScienCell Research Laboratories Revenue in Recombinant Human EGF Business (2015-2020)
10.14.5 ScienCell Research Laboratories Recent Development
13.15 BioVision, Inc
10.15.1 BioVision, Inc Company Details
10.15.2 BioVision, Inc Business Overview and Its Total Revenue
10.15.3 BioVision, Inc Recombinant Human EGF Introduction
10.15.4 BioVision, Inc Revenue in Recombinant Human EGF Business (2015-2020)
10.15.5 BioVision, Inc Recent Development
13.16 Abm Inc
10.16.1 Abm Inc Company Details
10.16.2 Abm Inc Business Overview and Its Total Revenue
10.16.3 Abm Inc Recombinant Human EGF Introduction
10.16.4 Abm Inc Revenue in Recombinant Human EGF Business (2015-2020)
10.16.5 Abm Inc Recent Development
13.17 Cell Guidance Systems
10.17.1 Cell Guidance Systems Company Details
10.17.2 Cell Guidance Systems Business Overview and Its Total Revenue
10.17.3 Cell Guidance Systems Recombinant Human EGF Introduction
10.17.4 Cell Guidance Systems Revenue in Recombinant Human EGF Business (2015-2020)
10.17.5 Cell Guidance Systems Recent Development
13.18 Creative BioMart
10.18.1 Creative BioMart Company Details
10.18.2 Creative BioMart Business Overview and Its Total Revenue
10.18.3 Creative BioMart Recombinant Human EGF Introduction
10.18.4 Creative BioMart Revenue in Recombinant Human EGF Business (2015-2020)
10.18.5 Creative BioMart Recent Development
13.19 Sino Biological
10.19.1 Sino Biological Company Details
10.19.2 Sino Biological Business Overview and Its Total Revenue
10.19.3 Sino Biological Recombinant Human EGF Introduction
10.19.4 Sino Biological Revenue in Recombinant Human EGF Business (2015-2020)
10.19.5 Sino Biological Recent Development
13.20 Cell Sciences
10.20.1 Cell Sciences Company Details
10.20.2 Cell Sciences Business Overview and Its Total Revenue
10.20.3 Cell Sciences Recombinant Human EGF Introduction
10.20.4 Cell Sciences Revenue in Recombinant Human EGF Business (2015-2020)
10.20.5 Cell Sciences Recent Development
13.21 Axol Bioscience
10.21.1 Axol Bioscience Company Details
10.21.2 Axol Bioscience Business Overview and Its Total Revenue
10.21.3 Axol Bioscience Recombinant Human EGF Introduction
10.21.4 Axol Bioscience Revenue in Recombinant Human EGF Business (2015-2020)
10.21.5 Axol Bioscience Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Recombinant Human EGF Revenue
1.4 Market Analysis by Type
1.4.1 Global Recombinant Human EGF Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 ?98% SDS-PAGE
1.4.3 95%-98% SDS-PAGE
1.4.4 <95% SDS-PAGE
1.5 Market by Application
1.5.1 Global Recombinant Human EGF Market Share by Application: 2020 VS 2026
1.5.2 Scientific Research
1.5.3 Medical Drug
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Recombinant Human EGF Industry Impact
1.6.1 How the Covid-19 is Affecting the Recombinant Human EGF Industry
1.6.1.1 Recombinant Human EGF Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Recombinant Human EGF Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Recombinant Human EGF Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Recombinant Human EGF Market Perspective (2015-2026)
2.2 Recombinant Human EGF Growth Trends by Regions
2.2.1 Recombinant Human EGF Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Recombinant Human EGF Historic Market Share by Regions (2015-2020)
2.2.3 Recombinant Human EGF Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Recombinant Human EGF Market Growth Strategy
2.3.6 Primary Interviews with Key Recombinant Human EGF Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Recombinant Human EGF Players by Market Size
3.1.1 Global Top Recombinant Human EGF Players by Revenue (2015-2020)
3.1.2 Global Recombinant Human EGF Revenue Market Share by Players (2015-2020)
3.1.3 Global Recombinant Human EGF Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Recombinant Human EGF Market Concentration Ratio
3.2.1 Global Recombinant Human EGF Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Recombinant Human EGF Revenue in 2019
3.3 Recombinant Human EGF Key Players Head office and Area Served
3.4 Key Players Recombinant Human EGF Product Solution and Service
3.5 Date of Enter into Recombinant Human EGF Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Recombinant Human EGF Historic Market Size by Type (2015-2020)
4.2 Global Recombinant Human EGF Forecasted Market Size by Type (2021-2026)
5 RECOMBINANT HUMAN EGF BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Recombinant Human EGF Market Size by Application (2015-2020)
5.2 Global Recombinant Human EGF Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Recombinant Human EGF Market Size (2015-2020)
6.2 Recombinant Human EGF Key Players in North America (2019-2020)
6.3 North America Recombinant Human EGF Market Size by Type (2015-2020)
6.4 North America Recombinant Human EGF Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Recombinant Human EGF Market Size (2015-2020)
7.2 Recombinant Human EGF Key Players in Europe (2019-2020)
7.3 Europe Recombinant Human EGF Market Size by Type (2015-2020)
7.4 Europe Recombinant Human EGF Market Size by Application (2015-2020)
8 CHINA
8.1 China Recombinant Human EGF Market Size (2015-2020)
8.2 Recombinant Human EGF Key Players in China (2019-2020)
8.3 China Recombinant Human EGF Market Size by Type (2015-2020)
8.4 China Recombinant Human EGF Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Recombinant Human EGF Market Size (2015-2020)
9.2 Recombinant Human EGF Key Players in Japan (2019-2020)
9.3 Japan Recombinant Human EGF Market Size by Type (2015-2020)
9.4 Japan Recombinant Human EGF Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Recombinant Human EGF Market Size (2015-2020)
10.2 Recombinant Human EGF Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Recombinant Human EGF Market Size by Type (2015-2020)
10.4 Southeast Asia Recombinant Human EGF Market Size by Application (2015-2020)
11 INDIA
11.1 India Recombinant Human EGF Market Size (2015-2020)
11.2 Recombinant Human EGF Key Players in India (2019-2020)
11.3 India Recombinant Human EGF Market Size by Type (2015-2020)
11.4 India Recombinant Human EGF Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Recombinant Human EGF Market Size (2015-2020)
12.2 Recombinant Human EGF Key Players in Central & South America (2019-2020)
12.3 Central & South America Recombinant Human EGF Market Size by Type (2015-2020)
12.4 Central & South America Recombinant Human EGF Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 FUJIFILM Irvine Scientific
13.1.1 FUJIFILM Irvine Scientific Company Details
13.1.2 FUJIFILM Irvine Scientific Business Overview and Its Total Revenue
13.1.3 FUJIFILM Irvine Scientific Recombinant Human EGF Introduction
13.1.4 FUJIFILM Irvine Scientific Revenue in Recombinant Human EGF Business (2015-2020))
13.1.5 FUJIFILM Irvine Scientific Recent Development
13.2 PeproTech, Inc
13.2.1 PeproTech, Inc Company Details
13.2.2 PeproTech, Inc Business Overview and Its Total Revenue
13.2.3 PeproTech, Inc Recombinant Human EGF Introduction
13.2.4 PeproTech, Inc Revenue in Recombinant Human EGF Business (2015-2020)
13.2.5 PeproTech, Inc Recent Development
13.3 R&D Systems (Bio-Techne)
13.3.1 R&D Systems (Bio-Techne) Company Details
13.3.2 R&D Systems (Bio-Techne) Business Overview and Its Total Revenue
13.3.3 R&D Systems (Bio-Techne) Recombinant Human EGF Introduction
13.3.4 R&D Systems (Bio-Techne) Revenue in Recombinant Human EGF Business (2015-2020)
13.3.5 R&D Systems (Bio-Techne) Recent Development
13.4 Miltenyi Biotec
13.4.1 Miltenyi Biotec Company Details
13.4.2 Miltenyi Biotec Business Overview and Its Total Revenue
13.4.3 Miltenyi Biotec Recombinant Human EGF Introduction
13.4.4 Miltenyi Biotec Revenue in Recombinant Human EGF Business (2015-2020)
13.4.5 Miltenyi Biotec Recent Development
13.5 Thermo Fisher Scientific
13.5.1 Thermo Fisher Scientific Company Details
13.5.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
13.5.3 Thermo Fisher Scientific Recombinant Human EGF Introduction
13.5.4 Thermo Fisher Scientific Revenue in Recombinant Human EGF Business (2015-2020)
13.5.5 Thermo Fisher Scientific Recent Development
13.6 Abcam PLC
13.6.1 Abcam PLC Company Details
13.6.2 Abcam PLC Business Overview and Its Total Revenue
13.6.3 Abcam PLC Recombinant Human EGF Introduction
13.6.4 Abcam PLC Revenue in Recombinant Human EGF Business (2015-2020)
13.6.5 Abcam PLC Recent Development
13.7 BioLegend Way
13.7.1 BioLegend Way Company Details
13.7.2 BioLegend Way Business Overview and Its Total Revenue
13.7.3 BioLegend Way Recombinant Human EGF Introduction
13.7.4 BioLegend Way Revenue in Recombinant Human EGF Business (2015-2020)
13.7.5 BioLegend Way Recent Development
13.8 STEMCELL Technologies
13.8.1 STEMCELL Technologies Company Details
13.8.2 STEMCELL Technologies Business Overview and Its Total Revenue
13.8.3 STEMCELL Technologies Recombinant Human EGF Introduction
13.8.4 STEMCELL Technologies Revenue in Recombinant Human EGF Business (2015-2020)
13.8.5 STEMCELL Technologies Recent Development
13.9 Eurofins DiscoverX
13.9.1 Eurofins DiscoverX Company Details
13.9.2 Eurofins DiscoverX Business Overview and Its Total Revenue
13.9.3 Eurofins DiscoverX Recombinant Human EGF Introduction
13.9.4 Eurofins DiscoverX Revenue in Recombinant Human EGF Business (2015-2020)
13.9.5 Eurofins DiscoverX Recent Development
13.10 RayBiotech, Inc
13.10.1 RayBiotech, Inc Company Details
13.10.2 RayBiotech, Inc Business Overview and Its Total Revenue
13.10.3 RayBiotech, Inc Recombinant Human EGF Introduction
13.10.4 RayBiotech, Inc Revenue in Recombinant Human EGF Business (2015-2020)
13.10.5 RayBiotech, Inc Recent Development
13.11 Prospec-Tany
10.11.1 Prospec-Tany Company Details
10.11.2 Prospec-Tany Business Overview and Its Total Revenue
10.11.3 Prospec-Tany Recombinant Human EGF Introduction
10.11.4 Prospec-Tany Revenue in Recombinant Human EGF Business (2015-2020)
10.11.5 Prospec-Tany Recent Development
13.12 Tonbo Biosciences
10.12.1 Tonbo Biosciences Company Details
10.12.2 Tonbo Biosciences Business Overview and Its Total Revenue
10.12.3 Tonbo Biosciences Recombinant Human EGF Introduction
10.12.4 Tonbo Biosciences Revenue in Recombinant Human EGF Business (2015-2020)
10.12.5 Tonbo Biosciences Recent Development
13.13 EnQuire Bio
10.13.1 EnQuire Bio Company Details
10.13.2 EnQuire Bio Business Overview and Its Total Revenue
10.13.3 EnQuire Bio Recombinant Human EGF Introduction
10.13.4 EnQuire Bio Revenue in Recombinant Human EGF Business (2015-2020)
10.13.5 EnQuire Bio Recent Development
13.14 ScienCell Research Laboratories
10.14.1 ScienCell Research Laboratories Company Details
10.14.2 ScienCell Research Laboratories Business Overview and Its Total Revenue
10.14.3 ScienCell Research Laboratories Recombinant Human EGF Introduction
10.14.4 ScienCell Research Laboratories Revenue in Recombinant Human EGF Business (2015-2020)
10.14.5 ScienCell Research Laboratories Recent Development
13.15 BioVision, Inc
10.15.1 BioVision, Inc Company Details
10.15.2 BioVision, Inc Business Overview and Its Total Revenue
10.15.3 BioVision, Inc Recombinant Human EGF Introduction
10.15.4 BioVision, Inc Revenue in Recombinant Human EGF Business (2015-2020)
10.15.5 BioVision, Inc Recent Development
13.16 Abm Inc
10.16.1 Abm Inc Company Details
10.16.2 Abm Inc Business Overview and Its Total Revenue
10.16.3 Abm Inc Recombinant Human EGF Introduction
10.16.4 Abm Inc Revenue in Recombinant Human EGF Business (2015-2020)
10.16.5 Abm Inc Recent Development
13.17 Cell Guidance Systems
10.17.1 Cell Guidance Systems Company Details
10.17.2 Cell Guidance Systems Business Overview and Its Total Revenue
10.17.3 Cell Guidance Systems Recombinant Human EGF Introduction
10.17.4 Cell Guidance Systems Revenue in Recombinant Human EGF Business (2015-2020)
10.17.5 Cell Guidance Systems Recent Development
13.18 Creative BioMart
10.18.1 Creative BioMart Company Details
10.18.2 Creative BioMart Business Overview and Its Total Revenue
10.18.3 Creative BioMart Recombinant Human EGF Introduction
10.18.4 Creative BioMart Revenue in Recombinant Human EGF Business (2015-2020)
10.18.5 Creative BioMart Recent Development
13.19 Sino Biological
10.19.1 Sino Biological Company Details
10.19.2 Sino Biological Business Overview and Its Total Revenue
10.19.3 Sino Biological Recombinant Human EGF Introduction
10.19.4 Sino Biological Revenue in Recombinant Human EGF Business (2015-2020)
10.19.5 Sino Biological Recent Development
13.20 Cell Sciences
10.20.1 Cell Sciences Company Details
10.20.2 Cell Sciences Business Overview and Its Total Revenue
10.20.3 Cell Sciences Recombinant Human EGF Introduction
10.20.4 Cell Sciences Revenue in Recombinant Human EGF Business (2015-2020)
10.20.5 Cell Sciences Recent Development
13.21 Axol Bioscience
10.21.1 Axol Bioscience Company Details
10.21.2 Axol Bioscience Business Overview and Its Total Revenue
10.21.3 Axol Bioscience Recombinant Human EGF Introduction
10.21.4 Axol Bioscience Revenue in Recombinant Human EGF Business (2015-2020)
10.21.5 Axol Bioscience Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Recombinant Human EGF Key Market Segments
Table 2. Key Players Covered: Ranking by Recombinant Human EGF Revenue
Table 3. Ranking of Global Top Recombinant Human EGF Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Recombinant Human EGF Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of ?98% SDS-PAGE
Table 6. Key Players of 95%-98% SDS-PAGE
Table 7. Key Players of <95% SDS-PAGE
Table 8. COVID-19 Impact Global Market: (Four Recombinant Human EGF Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Recombinant Human EGF Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Recombinant Human EGF Players to Combat Covid-19 Impact
Table 13. Global Recombinant Human EGF Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Recombinant Human EGF Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Recombinant Human EGF Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Recombinant Human EGF Market Share by Regions (2015-2020)
Table 17. Global Recombinant Human EGF Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Recombinant Human EGF Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Recombinant Human EGF Market Growth Strategy
Table 23. Main Points Interviewed from Key Recombinant Human EGF Players
Table 24. Global Recombinant Human EGF Revenue by Players (2015-2020) (Million US$)
Table 25. Global Recombinant Human EGF Market Share by Players (2015-2020)
Table 26. Global Top Recombinant Human EGF Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human EGF as of 2019)
Table 27. Global Recombinant Human EGF by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Recombinant Human EGF Product Solution and Service
Table 30. Date of Enter into Recombinant Human EGF Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 33. Global Recombinant Human EGF Market Size Share by Type (2015-2020)
Table 34. Global Recombinant Human EGF Revenue Market Share by Type (2021-2026)
Table 35. Global Recombinant Human EGF Market Size Share by Application (2015-2020)
Table 36. Global Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 37. Global Recombinant Human EGF Market Size Share by Application (2021-2026)
Table 38. North America Key Players Recombinant Human EGF Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Recombinant Human EGF Market Share (2019-2020)
Table 40. North America Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 41. North America Recombinant Human EGF Market Share by Type (2015-2020)
Table 42. North America Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 43. North America Recombinant Human EGF Market Share by Application (2015-2020)
Table 44. Europe Key Players Recombinant Human EGF Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Recombinant Human EGF Market Share (2019-2020)
Table 46. Europe Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Recombinant Human EGF Market Share by Type (2015-2020)
Table 48. Europe Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Recombinant Human EGF Market Share by Application (2015-2020)
Table 50. China Key Players Recombinant Human EGF Revenue (2019-2020) (Million US$)
Table 51. China Key Players Recombinant Human EGF Market Share (2019-2020)
Table 52. China Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 53. China Recombinant Human EGF Market Share by Type (2015-2020)
Table 54. China Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 55. China Recombinant Human EGF Market Share by Application (2015-2020)
Table 56. Japan Key Players Recombinant Human EGF Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Recombinant Human EGF Market Share (2019-2020)
Table 58. Japan Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Recombinant Human EGF Market Share by Type (2015-2020)
Table 60. Japan Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Recombinant Human EGF Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Recombinant Human EGF Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Recombinant Human EGF Market Share (2019-2020)
Table 64. Southeast Asia Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Recombinant Human EGF Market Share by Type (2015-2020)
Table 66. Southeast Asia Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Recombinant Human EGF Market Share by Application (2015-2020)
Table 68. India Key Players Recombinant Human EGF Revenue (2019-2020) (Million US$)
Table 69. India Key Players Recombinant Human EGF Market Share (2019-2020)
Table 70. India Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 71. India Recombinant Human EGF Market Share by Type (2015-2020)
Table 72. India Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 73. India Recombinant Human EGF Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Recombinant Human EGF Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Recombinant Human EGF Market Share (2019-2020)
Table 76. Central & South America Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Recombinant Human EGF Market Share by Type (2015-2020)
Table 78. Central & South America Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Recombinant Human EGF Market Share by Application (2015-2020)
Table 80. FUJIFILM Irvine Scientific Company Details
Table 81. FUJIFILM Irvine Scientific Business Overview
Table 82. FUJIFILM Irvine Scientific Product
Table 83. FUJIFILM Irvine Scientific Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 84. FUJIFILM Irvine Scientific Recent Development
Table 85. PeproTech, Inc Company Details
Table 86. PeproTech, Inc Business Overview
Table 87. PeproTech, Inc Product
Table 88. PeproTech, Inc Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 89. PeproTech, Inc Recent Development
Table 90. R&D Systems (Bio-Techne) Company Details
Table 91. R&D Systems (Bio-Techne) Business Overview
Table 92. R&D Systems (Bio-Techne) Product
Table 93. R&D Systems (Bio-Techne) Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 94. R&D Systems (Bio-Techne) Recent Development
Table 95. Miltenyi Biotec Company Details
Table 96. Miltenyi Biotec Business Overview
Table 97. Miltenyi Biotec Product
Table 98. Miltenyi Biotec Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 99. Miltenyi Biotec Recent Development
Table 100. Thermo Fisher Scientific Company Details
Table 101. Thermo Fisher Scientific Business Overview
Table 102. Thermo Fisher Scientific Product
Table 103. Thermo Fisher Scientific Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 104. Thermo Fisher Scientific Recent Development
Table 105. Abcam PLC Company Details
Table 106. Abcam PLC Business Overview
Table 107. Abcam PLC Product
Table 108. Abcam PLC Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 109. Abcam PLC Recent Development
Table 110. BioLegend Way Company Details
Table 111. BioLegend Way Business Overview
Table 112. BioLegend Way Product
Table 113. BioLegend Way Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 114. BioLegend Way Recent Development
Table 115. STEMCELL Technologies Business Overview
Table 116. STEMCELL Technologies Product
Table 117. STEMCELL Technologies Company Details
Table 118. STEMCELL Technologies Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 119. STEMCELL Technologies Recent Development
Table 120. Eurofins DiscoverX Company Details
Table 121. Eurofins DiscoverX Business Overview
Table 122. Eurofins DiscoverX Product
Table 123. Eurofins DiscoverX Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 124. Eurofins DiscoverX Recent Development
Table 125. RayBiotech, Inc Company Details
Table 126. RayBiotech, Inc Business Overview
Table 127. RayBiotech, Inc Product
Table 128. RayBiotech, Inc Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 129. RayBiotech, Inc Recent Development
Table 130. Prospec-Tany Company Details
Table 131. Prospec-Tany Business Overview
Table 132. Prospec-Tany Product
Table 133. Prospec-Tany Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 134. Prospec-Tany Recent Development
Table 135. Tonbo Biosciences Company Details
Table 136. Tonbo Biosciences Business Overview
Table 137. Tonbo Biosciences Product
Table 138. Tonbo Biosciences Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 139. Tonbo Biosciences Recent Development
Table 140. EnQuire Bio Company Details
Table 141. EnQuire Bio Business Overview
Table 142. EnQuire Bio Product
Table 143. EnQuire Bio Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 144. EnQuire Bio Recent Development
Table 145. ScienCell Research Laboratories Company Details
Table 146. ScienCell Research Laboratories Business Overview
Table 147. ScienCell Research Laboratories Product
Table 148. ScienCell Research Laboratories Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 149. ScienCell Research Laboratories Recent Development
Table 150. BioVision, Inc Company Details
Table 151. BioVision, Inc Business Overview
Table 152. BioVision, Inc Product
Table 153. BioVision, Inc Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 154. BioVision, Inc Recent Development
Table 155. Abm Inc Company Details
Table 156. Abm Inc Business Overview
Table 157. Abm Inc Product
Table 158. Abm Inc Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 159. Abm Inc Recent Development
Table 160. Cell Guidance Systems Company Details
Table 161. Cell Guidance Systems Business Overview
Table 162. Cell Guidance Systems Product
Table 163. Cell Guidance Systems Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 164. Cell Guidance Systems Recent Development
Table 165. Creative BioMart Company Details
Table 166. Creative BioMart Business Overview
Table 167. Creative BioMart Product
Table 168. Creative BioMart Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 169. Creative BioMart Recent Development
Table 170. Sino Biological Company Details
Table 171. Sino Biological Business Overview
Table 172. Sino Biological Product
Table 173. Sino Biological Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 174. Sino Biological Recent Development
Table 175. Cell Sciences Company Details
Table 176. Cell Sciences Business Overview
Table 177. Cell Sciences Product
Table 178. Cell Sciences Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 179. Cell Sciences Recent Development
Table 180. Axol Bioscience Company Details
Table 181. Axol Bioscience Business Overview
Table 182. Axol Bioscience Product
Table 183. Axol Bioscience Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 184. Axol Bioscience Recent Development
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
Table 1. Recombinant Human EGF Key Market Segments
Table 2. Key Players Covered: Ranking by Recombinant Human EGF Revenue
Table 3. Ranking of Global Top Recombinant Human EGF Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Recombinant Human EGF Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of ?98% SDS-PAGE
Table 6. Key Players of 95%-98% SDS-PAGE
Table 7. Key Players of <95% SDS-PAGE
Table 8. COVID-19 Impact Global Market: (Four Recombinant Human EGF Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Recombinant Human EGF Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Recombinant Human EGF Players to Combat Covid-19 Impact
Table 13. Global Recombinant Human EGF Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Recombinant Human EGF Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Recombinant Human EGF Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Recombinant Human EGF Market Share by Regions (2015-2020)
Table 17. Global Recombinant Human EGF Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Recombinant Human EGF Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Recombinant Human EGF Market Growth Strategy
Table 23. Main Points Interviewed from Key Recombinant Human EGF Players
Table 24. Global Recombinant Human EGF Revenue by Players (2015-2020) (Million US$)
Table 25. Global Recombinant Human EGF Market Share by Players (2015-2020)
Table 26. Global Top Recombinant Human EGF Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human EGF as of 2019)
Table 27. Global Recombinant Human EGF by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Recombinant Human EGF Product Solution and Service
Table 30. Date of Enter into Recombinant Human EGF Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 33. Global Recombinant Human EGF Market Size Share by Type (2015-2020)
Table 34. Global Recombinant Human EGF Revenue Market Share by Type (2021-2026)
Table 35. Global Recombinant Human EGF Market Size Share by Application (2015-2020)
Table 36. Global Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 37. Global Recombinant Human EGF Market Size Share by Application (2021-2026)
Table 38. North America Key Players Recombinant Human EGF Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Recombinant Human EGF Market Share (2019-2020)
Table 40. North America Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 41. North America Recombinant Human EGF Market Share by Type (2015-2020)
Table 42. North America Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 43. North America Recombinant Human EGF Market Share by Application (2015-2020)
Table 44. Europe Key Players Recombinant Human EGF Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Recombinant Human EGF Market Share (2019-2020)
Table 46. Europe Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Recombinant Human EGF Market Share by Type (2015-2020)
Table 48. Europe Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Recombinant Human EGF Market Share by Application (2015-2020)
Table 50. China Key Players Recombinant Human EGF Revenue (2019-2020) (Million US$)
Table 51. China Key Players Recombinant Human EGF Market Share (2019-2020)
Table 52. China Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 53. China Recombinant Human EGF Market Share by Type (2015-2020)
Table 54. China Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 55. China Recombinant Human EGF Market Share by Application (2015-2020)
Table 56. Japan Key Players Recombinant Human EGF Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Recombinant Human EGF Market Share (2019-2020)
Table 58. Japan Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Recombinant Human EGF Market Share by Type (2015-2020)
Table 60. Japan Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Recombinant Human EGF Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Recombinant Human EGF Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Recombinant Human EGF Market Share (2019-2020)
Table 64. Southeast Asia Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Recombinant Human EGF Market Share by Type (2015-2020)
Table 66. Southeast Asia Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Recombinant Human EGF Market Share by Application (2015-2020)
Table 68. India Key Players Recombinant Human EGF Revenue (2019-2020) (Million US$)
Table 69. India Key Players Recombinant Human EGF Market Share (2019-2020)
Table 70. India Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 71. India Recombinant Human EGF Market Share by Type (2015-2020)
Table 72. India Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 73. India Recombinant Human EGF Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Recombinant Human EGF Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Recombinant Human EGF Market Share (2019-2020)
Table 76. Central & South America Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Recombinant Human EGF Market Share by Type (2015-2020)
Table 78. Central & South America Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Recombinant Human EGF Market Share by Application (2015-2020)
Table 80. FUJIFILM Irvine Scientific Company Details
Table 81. FUJIFILM Irvine Scientific Business Overview
Table 82. FUJIFILM Irvine Scientific Product
Table 83. FUJIFILM Irvine Scientific Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 84. FUJIFILM Irvine Scientific Recent Development
Table 85. PeproTech, Inc Company Details
Table 86. PeproTech, Inc Business Overview
Table 87. PeproTech, Inc Product
Table 88. PeproTech, Inc Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 89. PeproTech, Inc Recent Development
Table 90. R&D Systems (Bio-Techne) Company Details
Table 91. R&D Systems (Bio-Techne) Business Overview
Table 92. R&D Systems (Bio-Techne) Product
Table 93. R&D Systems (Bio-Techne) Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 94. R&D Systems (Bio-Techne) Recent Development
Table 95. Miltenyi Biotec Company Details
Table 96. Miltenyi Biotec Business Overview
Table 97. Miltenyi Biotec Product
Table 98. Miltenyi Biotec Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 99. Miltenyi Biotec Recent Development
Table 100. Thermo Fisher Scientific Company Details
Table 101. Thermo Fisher Scientific Business Overview
Table 102. Thermo Fisher Scientific Product
Table 103. Thermo Fisher Scientific Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 104. Thermo Fisher Scientific Recent Development
Table 105. Abcam PLC Company Details
Table 106. Abcam PLC Business Overview
Table 107. Abcam PLC Product
Table 108. Abcam PLC Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 109. Abcam PLC Recent Development
Table 110. BioLegend Way Company Details
Table 111. BioLegend Way Business Overview
Table 112. BioLegend Way Product
Table 113. BioLegend Way Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 114. BioLegend Way Recent Development
Table 115. STEMCELL Technologies Business Overview
Table 116. STEMCELL Technologies Product
Table 117. STEMCELL Technologies Company Details
Table 118. STEMCELL Technologies Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 119. STEMCELL Technologies Recent Development
Table 120. Eurofins DiscoverX Company Details
Table 121. Eurofins DiscoverX Business Overview
Table 122. Eurofins DiscoverX Product
Table 123. Eurofins DiscoverX Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 124. Eurofins DiscoverX Recent Development
Table 125. RayBiotech, Inc Company Details
Table 126. RayBiotech, Inc Business Overview
Table 127. RayBiotech, Inc Product
Table 128. RayBiotech, Inc Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 129. RayBiotech, Inc Recent Development
Table 130. Prospec-Tany Company Details
Table 131. Prospec-Tany Business Overview
Table 132. Prospec-Tany Product
Table 133. Prospec-Tany Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 134. Prospec-Tany Recent Development
Table 135. Tonbo Biosciences Company Details
Table 136. Tonbo Biosciences Business Overview
Table 137. Tonbo Biosciences Product
Table 138. Tonbo Biosciences Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 139. Tonbo Biosciences Recent Development
Table 140. EnQuire Bio Company Details
Table 141. EnQuire Bio Business Overview
Table 142. EnQuire Bio Product
Table 143. EnQuire Bio Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 144. EnQuire Bio Recent Development
Table 145. ScienCell Research Laboratories Company Details
Table 146. ScienCell Research Laboratories Business Overview
Table 147. ScienCell Research Laboratories Product
Table 148. ScienCell Research Laboratories Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 149. ScienCell Research Laboratories Recent Development
Table 150. BioVision, Inc Company Details
Table 151. BioVision, Inc Business Overview
Table 152. BioVision, Inc Product
Table 153. BioVision, Inc Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 154. BioVision, Inc Recent Development
Table 155. Abm Inc Company Details
Table 156. Abm Inc Business Overview
Table 157. Abm Inc Product
Table 158. Abm Inc Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 159. Abm Inc Recent Development
Table 160. Cell Guidance Systems Company Details
Table 161. Cell Guidance Systems Business Overview
Table 162. Cell Guidance Systems Product
Table 163. Cell Guidance Systems Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 164. Cell Guidance Systems Recent Development
Table 165. Creative BioMart Company Details
Table 166. Creative BioMart Business Overview
Table 167. Creative BioMart Product
Table 168. Creative BioMart Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 169. Creative BioMart Recent Development
Table 170. Sino Biological Company Details
Table 171. Sino Biological Business Overview
Table 172. Sino Biological Product
Table 173. Sino Biological Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 174. Sino Biological Recent Development
Table 175. Cell Sciences Company Details
Table 176. Cell Sciences Business Overview
Table 177. Cell Sciences Product
Table 178. Cell Sciences Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 179. Cell Sciences Recent Development
Table 180. Axol Bioscience Company Details
Table 181. Axol Bioscience Business Overview
Table 182. Axol Bioscience Product
Table 183. Axol Bioscience Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 184. Axol Bioscience Recent Development
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Recombinant Human EGF Market Share by Type: 2020 VS 2026
Figure 2. ?98% SDS-PAGE Features
Figure 3. 95%-98% SDS-PAGE Features
Figure 4. <95% SDS-PAGE Features
Figure 5. Global Recombinant Human EGF Market Share by Application: 2020 VS 2026
Figure 6. Scientific Research Case Studies
Figure 7. Medical Drug Case Studies
Figure 8. Others Case Studies
Figure 9. Recombinant Human EGF Report Years Considered
Figure 10. Global Recombinant Human EGF Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Recombinant Human EGF Market Share by Regions: 2020 VS 2026
Figure 12. Global Recombinant Human EGF Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Recombinant Human EGF Market Share by Players in 2019
Figure 15. Global Top Recombinant Human EGF Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human EGF as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Recombinant Human EGF Revenue in 2019
Figure 17. North America Recombinant Human EGF Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Recombinant Human EGF Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Recombinant Human EGF Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Recombinant Human EGF Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Recombinant Human EGF Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Recombinant Human EGF Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Recombinant Human EGF Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. FUJIFILM Irvine Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. FUJIFILM Irvine Scientific Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 26. PeproTech, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. PeproTech, Inc Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 28. R&D Systems (Bio-Techne) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. R&D Systems (Bio-Techne) Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 30. Miltenyi Biotec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Miltenyi Biotec Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 32. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Thermo Fisher Scientific Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 34. Abcam PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Abcam PLC Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 36. BioLegend Way Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. BioLegend Way Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 38. STEMCELL Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. STEMCELL Technologies Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 40. Eurofins DiscoverX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Eurofins DiscoverX Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 42. RayBiotech, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. RayBiotech, Inc Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 44. Prospec-Tany Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Prospec-Tany Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 46. Tonbo Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Tonbo Biosciences Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 48. EnQuire Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. EnQuire Bio Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 50. ScienCell Research Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. ScienCell Research Laboratories Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 52. BioVision, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. BioVision, Inc Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 54. Abm Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Abm Inc Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 56. Cell Guidance Systems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Cell Guidance Systems Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 58. Creative BioMart Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Creative BioMart Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 60. Sino Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Sino Biological Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 62. Cell Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Cell Sciences Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Figure 1. Global Recombinant Human EGF Market Share by Type: 2020 VS 2026
Figure 2. ?98% SDS-PAGE Features
Figure 3. 95%-98% SDS-PAGE Features
Figure 4. <95% SDS-PAGE Features
Figure 5. Global Recombinant Human EGF Market Share by Application: 2020 VS 2026
Figure 6. Scientific Research Case Studies
Figure 7. Medical Drug Case Studies
Figure 8. Others Case Studies
Figure 9. Recombinant Human EGF Report Years Considered
Figure 10. Global Recombinant Human EGF Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Recombinant Human EGF Market Share by Regions: 2020 VS 2026
Figure 12. Global Recombinant Human EGF Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Recombinant Human EGF Market Share by Players in 2019
Figure 15. Global Top Recombinant Human EGF Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human EGF as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Recombinant Human EGF Revenue in 2019
Figure 17. North America Recombinant Human EGF Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Recombinant Human EGF Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Recombinant Human EGF Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Recombinant Human EGF Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Recombinant Human EGF Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Recombinant Human EGF Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Recombinant Human EGF Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. FUJIFILM Irvine Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. FUJIFILM Irvine Scientific Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 26. PeproTech, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. PeproTech, Inc Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 28. R&D Systems (Bio-Techne) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. R&D Systems (Bio-Techne) Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 30. Miltenyi Biotec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Miltenyi Biotec Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 32. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Thermo Fisher Scientific Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 34. Abcam PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Abcam PLC Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 36. BioLegend Way Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. BioLegend Way Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 38. STEMCELL Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. STEMCELL Technologies Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 40. Eurofins DiscoverX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Eurofins DiscoverX Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 42. RayBiotech, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. RayBiotech, Inc Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 44. Prospec-Tany Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Prospec-Tany Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 46. Tonbo Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Tonbo Biosciences Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 48. EnQuire Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. EnQuire Bio Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 50. ScienCell Research Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. ScienCell Research Laboratories Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 52. BioVision, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. BioVision, Inc Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 54. Abm Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Abm Inc Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 56. Cell Guidance Systems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Cell Guidance Systems Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 58. Creative BioMart Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Creative BioMart Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 60. Sino Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Sino Biological Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 62. Cell Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Cell Sciences Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
